AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31498137
Drug: Constraint-Induced Movement
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constraint-Induced Movement Therapy (CIMT) - less affected limb blocked by a splint
Trial: 24228803
Drug: DHA (500mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA (500mg daily)
Trial: 24228803
Drug: DHA plus
RxNorm normalized name: PNV-DHA Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA plus EPA mixture (500mg daily)
Trial: 16080791
Drug: Lactobacillus fermentum
RxNorm normalized name: Lactobacillus Fermentum
DrugBank: Lactobacillus fermentum (DB16542)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus fermentum ME‐3 in fermented goat milk (daily dose 11.8 log CFU)
Trial: 16080791
Drug: Lactobacillus fermentum
RxNorm normalized name: Lactobacillus Fermentum
DrugBank: Lactobacillus fermentum (DB16542)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus fermentum ME‐3 in capsules (daily dose 9.2 CFU)
Trial: 7995059
Drug: Second pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second pulse therapy (at 24h and 48h)
Trial: 1695053
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMW heparin)
Trial: 2838681
Drug: Standard unfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard unfractionated heparin (UF heparin)
Trial: 14605030
Drug: Abrupt discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrupt discontinuation of nitrate treatment (study group)
Trial: 3890700
Drug: Mesulergine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesulergine 20 mg daily
Trial: 20454927
Drug: Ixabepilone plus
RxNorm normalized name: Ixabepilone
DrugBank: Ixabepilone (DB04845)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ixabepilone plus capecitabine (40 mg/m² intravenously on day 1 of a 21-day cycle plus 2,000 mg/m² orally on days 1-14 of a 21-day cycle)
Trial: 20454927
Drug: Capecitabine alone
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine alone (2,500 mg/m² on the same schedule)
Trial: 15900423
Drug: External-beam irradiation
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External-beam irradiation administered as a 40-Gy dose under normal oxygenation conditions
Trial: 15900423
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose under normoxic conditions
Trial: 31467066
Drug: Long-acting G-CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting G-CSF for all chemotherapy cycles
Trial: 27932353
Drug: Ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (10 mg/d) + Statin (E+S)
Trial: 27932353
Drug: Statin Monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin Monotherapy (S)
Trial: 23606983
Drug: Montelukast (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (5 mg at bed time)
Trial: 26578849
Drug: Dabigatran 220
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 220 mg once daily
Trial: 19923527
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg IV before incision, 24-h infusion at 2 microg x kg(‐1) x min(‐1))
Trial: 19923527
Drug: Placebo (blinded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (blinded saline bolus and infusion)
Trial: 17352522
Drug: Clopidogrel added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel added to aspirin therapy
Trial: 11563412
Drug: Zolpidem 10
RxNorm normalized name: zolpidem 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 10 mg with sertraline 50 mg
Trial: 1782951
Drug: alteplase 100
RxNorm normalized name: alteplase 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alteplase 100 mg in 3 h
Trial: 27893045
Drug: Chlorthalidone (thiazide-type
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (thiazide-type diuretic)
Trial: 25087908
Drug: Oxytocin nasal
RxNorm normalized name: oxytocin Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin nasal spray (18 or 24 International Units), administered twice-daily for 8 weeks
Trial: 25087908
Drug: Placebo nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nasal spray, administered twice-daily for 8 weeks
Trial: 19265481
Drug: Control subjects
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control subjects (first dose of vaccine)
Trial: 9552772
Drug: 2-Chloroprocaine (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-Chloroprocaine (90 mg)
Trial: 8022626
Drug: Bupivacaine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (25 mg)
Trial: 9552772
Drug: 2-Chloroprocaine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-Chloroprocaine (60 mg)
Trial: 15671224
Drug: Daily iron
RxNorm normalized name: Walgreens Multivitamin One Daily Iron-Free Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron (125 mg FeSO4, 10 microg folate, 25 mg vitamin C)
Trial: 15671224
Drug: Placebo (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (10 microg folate and 25 mg vitamin C)
Trial: 8932539
Drug: AC137 30-mug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AC137 30-mug infusion dose
Trial: 8932539
Drug: AC137 300-mug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AC137 300-mug infusion dose
Trial: 1763292
Drug: Budesonide 1
RxNorm normalized name: BUDESONIDE 1MG/2ML SUSP,INH,2ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 1 mg/100 ml
Trial: 1763292
Drug: Budesonide 2
RxNorm normalized name: budesonide 2 MG/ACTUAT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 2 mg/100 ml
Trial: 26979470
Drug: Daily physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily physical activities (DA)
Trial: 23216943
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with etanercept and standardized HRQoL assessment and communication
Trial: 23216943
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with etanercept alone
Trial: 20973707
Drug: Methylphenidate transdermal
RxNorm normalized name: methylphenidate Transdermal System
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate transdermal system (MTS) 10-30 mg/9 hours
Trial: 20492851
Drug: Placebo transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo transdermal system (PTS)
Trial: 12492613
Drug: Quinine sulphate
RxNorm normalized name: Quinine sulphate
DrugBank: Quinine (DB00468)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quinine sulphate (600 mg) alone
Trial: 12492613
Drug: Quinine sulphate
RxNorm normalized name: Quinine sulphate
DrugBank: Quinine (DB00468)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quinine sulphate (600 mg) plus troleandomycin (TAO; 500 mg every 8 h)
Trial: 9475328
Drug: Albuterol (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (180 microg b.i.d.)
Trial: 30766
Drug: Lorazepam (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (3 mg/day: 2 mg in the evening and 1 mg in the morning)
Trial: 31514233
Drug: Prednisone (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (0.4 mg/kg/d for 15 days, then 0.2 mg/kg/d for 15 days)
Trial: 29251976
Drug: 15.8 mg/g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15.8 mg/g Spectrum cigarette
Trial: 29251976
Drug: 5.2 mg/g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.2 mg/g Spectrum cigarette
Trial: 29251976
Drug: 2.4 mg/g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.4 mg/g Spectrum cigarette
Trial: 24067879
Drug: Telbivudine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telbivudine (600 mg/d)
Trial: 26236924
Drug: Entecavir (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entecavir (0.5 mg/d)
Trial: 16998208
Drug: Physician's treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physician's treatment (control)
Trial: 11740759
Drug: Fixed minidose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed minidose warfarin (2 mg daily)
Trial: 8453847
Drug: Ciprofloxacin alone
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin alone (750 mg)
Trial: 25229980
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg · kg(‐1) OM)
Trial: 25229980
Drug: Intranasal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dexmedetomidine (2 μg · kg(‐1) IND)
Trial: 25229980
Drug: Placebo (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral honey and intranasal saline)
Trial: 16431379
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg (two pills)
Trial: 12845759
Drug: Cisapride 5
RxNorm normalized name: cisapride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 5 mg three times a day
Trial: 12845759
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg three times a day
Trial: 9216948
Drug: Saline inhalation
RxNorm normalized name: Broncho Saline Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline inhalation (Control)
Trial: 29178746
Drug: Power toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Power toothbrush (Oral-B Professional Care 7000)
Trial: 23688422
Drug: 1000 μg
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 μg fluticasone propionate (FP)
Trial: 14649610
Drug: Midazolam alone
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam alone (Group A: 1 mg/kg)
Trial: 14649610
Drug: Midazolam plus
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam plus meperidine (Group B: 0.5 and 1 mg/kg)
Trial: 8774204
Drug: Standard intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intravenous heparin protocol
Trial: 25147364
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (0.1 mg/kg)
Trial: 29762444
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma injection
Trial: 16144892
Drug: Rosiglitazone, 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone, 8 g/d
Trial: 12696778
Drug: Oral oxybutynin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxybutynin 5 mg t.i.d. (Group II)
Trial: 2197335
Drug: Avian-human influenza
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccine (10(3)-10(7) TCID50)
Trial: 2197335
Drug: Cold-adapted influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold-adapted influenza A/Bethesda/85 (H3N2) reassortant virus vaccine (10(3)-10(7) TCID50)
Trial: 7423160
Drug: 3 daily
RxNorm normalized name: ombitasvir
DrugBank: Ombitasvir (DB09296)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 3 daily doses of 220 mg zinc sulfate (group B)
Trial: 7423160
Drug: No zinc
RxNorm normalized name: ZINC OXIDE 140 mg in 1 mL TOPICAL CREAM [Lucin Organics Tinted Sunscreen SPF 30 Non Nano Zinc Oxide]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No zinc therapy (group A)
Trial: 30819765
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy + temozolomide
Trial: 28039050
Drug: HCG administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCG administration (250 IU intramuscularly 3 times per week for 4 weeks)
Trial: 28039050
Drug: HCG administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCG administration
Trial: 23566033
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose (group A)
Trial: 9226739
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg idazoxan
Trial: 10365924
Drug: Finasteride 1
RxNorm normalized name: finasteride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 1 mg/day
Trial: 3317958
Drug: Lugol's iodine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lugol's iodine, 0.3 ml thrice daily for 9 days
Trial: 24016490
Drug: Aleglitazar 150
RxNorm normalized name: Aleglitazar
DrugBank: Aleglitazar (DB08915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aleglitazar 150 μg daily in addition to standard medical therapy
Trial: 26678626
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily in addition to standard medical therapy
Trial: 26093872
Drug: Aleglitazar 150
RxNorm normalized name: Aleglitazar
DrugBank: Aleglitazar (DB08915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aleglitazar 150 μg daily
Trial: 7626592
Drug: Psyllium and
RxNorm normalized name: Psyllium and senna only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium and psyllium-citrus pectin mixture (2.2 g)
Trial: 1782972
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl 75 micrograms/h (Fentanyl‐TTS)
Trial: 7075190
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg Sulprostone at 4 hourly intervals for 8 doses
Trial: 31058986
Drug: Spray 1
RxNorm normalized name: FLUORI-METHANE TOP SPRAY 120ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spray 1
Trial: 23482590
Drug: DAG (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAG (4 μg/kg per h) infused over 210 min
Trial: 23592479
Drug: Ghrelin administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ghrelin administration
Trial: 11352778
Drug: Bovine colostrum
RxNorm normalized name: Bovine Colostrum
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine colostrum (125 ml, tds) co-administered with indomethacin (50 mg, tds)
Trial: 11352778
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg, tds) with whey protein (control)
Trial: 11352778
Drug: Colostral solutions
RxNorm normalized name: COLOSTRUM
DrugBank: Human colostrum (DB19286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colostral solutions (125 ml, tds)
Trial: 11352778
Drug: Control solutions
RxNorm normalized name: Accu-Chek Comfort Curve Control Solutions
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solutions (125 ml, tds)
Trial: 9209895
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg metoclopramide (MTC) intravenous bolus after a 2-h saline infusion
Trial: 9209895
Drug: 4-h dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-h dopamine infusion at 0.01 microgram/kg/min with a 10 mg intravenous bolus of MTC given at the second hour of dopamine infusion
Trial: 9209895
Drug: 4-h saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-h saline infusion
Trial: 2048592
Drug: 35 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 micrograms ethinyl estradiol and 0.5 mg norethindrone
Trial: 3610737
Drug: 50 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 micrograms mestranol and 1.0 mg norethindrone
Trial: 28296201
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with lixisenatide and basal insulin (LIX group)
Trial: 28296201
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily insulin injection therapy (MDI group)
Trial: 29300991
Drug: Insulin-induced hypoglycemia
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-induced hypoglycemia
Trial: 93043
Drug: tocainide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tocainide (400 or 600 mg every eight hours)
Trial: 26076171
Drug: Morphine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (40 mg immediate release tablet)
Trial: 20500802
Drug: Cerebrolysin 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin 60 ml
Trial: 9674619
Drug: Mailed intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mailed intervention containing guidelines for the use of sedative hypnotics, a prescriber profile detailing sedative hypnotic prescribing, and a patient profile
Trial: 7639342
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg d-alpha-tocopherol per day for 3 weeks
Trial: 29691559
Drug: Hoshino's triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hoshino's triple antibiotic paste (Control)
Trial: 14587651
Drug: Rilmenidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilmenidine (1 mg/day)
Trial: 1910795
Drug: 360 ml
RxNorm normalized name: colostomy bags 10" 360 mL MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 ml of apple juice, 150 mg of oral ranitidine (two doses), 10 mg of metoclopramide
Trial: 1910795
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral fluids or acid aspiration prophylaxis
Trial: 30489177
Drug: Tofacitinib low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tofacitinib low-dose (1 or 3 mg) with low-dose MTX
Trial: 30489177
Drug: Tofacitinib 5
RxNorm normalized name: tofacitinib 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 5 mg BID with low-dose MTX
Trial: 30489177
Drug: Tofacitinib 10
RxNorm normalized name: tofacitinib 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 10 mg BID with high-dose MTX
Trial: 30489177
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with low-dose MTX
Trial: 30489177
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with high-dose MTX
Trial: 23565740
Drug: Vildagliptin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin (50 mg twice daily)
Trial: 8394849
Drug: Dalteparin sodium
RxNorm normalized name: Dalteparin Sodium
DrugBank: Dalteparin (DB06779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin sodium (10,000 IU daily for weeks 1 and 2, 5,000 IU daily for weeks 3 and 4)
Trial: 27391158
Drug: CRT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRT plus consolidation chemotherapy
Trial: 24535848
Drug: Psychoeducation using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoeducation using a tablet PC during chemotherapy infusion (n=19)
Trial: 18932271
Drug: Rasagiline (neuroprotective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline (neuroprotective therapy)
Trial: 12870166
Drug: 20% Intralipid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% Intralipid infusion (0.4 mL(‐1) x kg(‐1) x h(‐1))
Trial: 10420420
Drug: Three-dose emotional
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dose emotional expression writing group
Trial: 7194061
Drug: etofylline clofibrate
RxNorm normalized name: etofylline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etofylline clofibrate (3 x 250 mg)
Trial: 7194061
Drug: standard preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: standard preparation (clofibrate 3 x 500 mg and beta-pyridylcarbinol hydrogentartrate 3 x 25 mg)
Trial: 29768709
Drug: IMQ (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMQ (5 mg) applied once daily for 72 hours under occlusion to intact skin (n = 8)
Trial: 26500351
Drug: Tafenoquine (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tafenoquine (50, 100, 300, or 600 mg) plus chloroquine
Trial: 24268371
Drug: Standard 14-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 14-day quadruple treatment (Rabeprazole 20mg-bid, bismuth subcitrate 120 mg-qid, Tetracycline 500 mg-qid, Metronidazole 500 mg-tid for 2 weeks)
Trial: 24268371
Drug: 10-day sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day sequential therapy (20 mg rabeprazole and 1g amoxicillin twice daily for the first 5 days, followed by standard quadruple treatment for the remaining 5 days)
Trial: 20199521
Drug: Rufinamide (25-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rufinamide (25-60 mg/kg/day)
Trial: 31592939
Drug: Probiotic supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic supplementation (1.6 × 10 colony‐forming units of Lactobacillus rhamnosus capsules)
Trial: 31592939
Drug: Placebo control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo control (maltodextrin capsules)